Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04457245 · ClinicalTrials.gov registry record · Phase 3
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer
A Phase 3 study, sponsored by Jonsson Comprehensive Cancer Center.
- Terminated
- Registry status
- Phase 3
- Development phase
- 54
- Enrollment target
NCT04457245 is a Phase 3 study that was terminated before completion, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 54 participants.
The verdict
NCT04457245, a Phase 3 study, was terminated before completion, sponsored by Jonsson Comprehensive Cancer Center.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 54 participants
- Enrollment target
Study Summary
This randomized phase III trial studies the success rate of definitive radiation therapy (dRT) for prostate cancer (PCa) with or without planning based on PSMA PET. PSMA- PET-based dRT, may improve radiation therapy planning and patient selection for dRT, and potentially improve its outcome compared to dRT without PSMA PET (standard dRT).
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Positron Emission Tomography
- RADIATION Radiation Therapy
- OTHER Fluorine F 18 DCFPyL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2020-08-14 |
| Est. Completion | 2023-01-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04457245
The ClinicalTrials.gov registry entry for NCT04457245 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Computed Tomography is the first listed.
NCT04457245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04457245 about?
NCT04457245 is a clinical study titled "Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer". This randomized phase III trial studies the success rate of definitive radiation therapy (dRT) for prostate cancer (PCa) with or without planning based on PSMA PET. PSMA- PET-based dRT, may improve radiation therapy planning and patient selection for dRT, and potentially improve its outcome compared...
What is the current status of trial NCT04457245?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 54 participants. The study started on 2020-08-14. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT04457245?
The interventions under investigation include: Computed Tomography (PROCEDURE), Positron Emission Tomography (PROCEDURE), Radiation Therapy (RADIATION), Fluorine F 18 DCFPyL (OTHER).
Who is sponsoring clinical trial NCT04457245?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.